Lunai Bioworks (LNAI) Other Non Operating Income (2013 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Other Non Operating Income of -$19966.0 in Q1 2026, up 99.68% quarter-over-quarter from -$6.3 million in Q3 2025.
Lunai Bioworks (LNAI) Other Non Operating Income (2013 - 2026) Analysis & Trends
Lunai Bioworks' Other Non Operating Income history runs 14 years deep, the most recent figure standing at -$19966.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income changed N/A year-over-year to -$19966.0; the TTM figure through Mar 2026 stood at -$6.2 million (down 429.66% YoY), while the FY2025 annual figure was $116346.0, up 108.17% from the prior year.
- Other Non Operating Income was -$19966.0 for Q1 2026 at Lunai Bioworks, up from -$6.3 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $292562.0 in Q2 2023 to a low of -$6.3 million in Q3 2025.
- Historically, Other Non Operating Income has averaged -$957085.4 across 5 years, with a median of -$69992.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income slumped 4657677.78% in 2022, then soared 205.48% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at -$419182.0 in 2022, then soared by 71.37% to -$120018.0 in 2023, then jumped by 205.48% to $126598.0 in 2024, then slumped by 5099.76% to -$6.3 million in 2025, then soared by 99.68% to -$19966.0 in 2026.
- The last three Other Non Operating Income figures came in at -$19966.0 (Q1 2026), -$6.3 million (Q3 2025), and $116346.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19,966.00 |
| Sep 30, 2025 | -6.33 Mn |
| Jun 30, 2025 | 116,346.00 |
| Sep 30, 2024 | 126,598.00 |
| Jun 30, 2024 | -1.30 Mn |
| Sep 30, 2023 | -120,018.00 |
| Jun 30, 2023 | 292,562.00 |
| Sep 30, 2022 | -419,182.00 |
| Sep 30, 2021 | 9.00 |
| Jun 30, 2021 | -124.00 |
| Mar 31, 2021 | -221.00 |
| Dec 31, 2020 | -32,289.00 |
| Jun 30, 2020 | -8,936.00 |
| Mar 31, 2020 | -371.00 |
| Dec 31, 2019 | -151,755.00 |
| Sep 30, 2019 | 286,755.00 |
| Jun 30, 2019 | 11,034.00 |
| Mar 31, 2019 | 164,114.00 |
| Dec 31, 2018 | -169,483.00 |
| Sep 30, 2018 | -31,978.00 |